Assenagon Asset Management S.A. Takes Position in Teladoc Health, Inc. (NYSE:TDOC)

Assenagon Asset Management S.A. acquired a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 1,721,258 shares of the health services provider's stock, valued at approximately $15,801,000. Assenagon Asset Management S.A. owned 1.01% of Teladoc Health as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Teladoc Health by 2.1% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider's stock valued at $641,000 after buying an additional 1,352 shares during the period. Covestor Ltd lifted its stake in Teladoc Health by 58.1% during the first quarter. Covestor Ltd now owns 3,817 shares of the health services provider's stock worth $57,000 after purchasing an additional 1,403 shares during the last quarter. Westside Investment Management Inc. lifted its stake in Teladoc Health by 37.7% during the first quarter. Westside Investment Management Inc. now owns 5,662 shares of the health services provider's stock worth $85,000 after purchasing an additional 1,550 shares during the last quarter. Signaturefd LLC lifted its stake in Teladoc Health by 148.7% during the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider's stock worth $28,000 after purchasing an additional 1,715 shares during the last quarter. Finally, Swiss National Bank lifted its stake in Teladoc Health by 0.6% during the first quarter. Swiss National Bank now owns 326,902 shares of the health services provider's stock worth $4,936,000 after purchasing an additional 1,800 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Stock Performance

Shares of NYSE:TDOC traded down $0.03 during trading on Friday, reaching $8.57. The company had a trading volume of 3,834,089 shares, compared to its average volume of 5,429,968. The stock's fifty day moving average price is $8.30 and its 200 day moving average price is $9.80. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $22.54. The firm has a market capitalization of $1.45 billion, a price-to-earnings ratio of -6.08 and a beta of 0.91. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, topping analysts' consensus estimates of ($0.36) by $0.08. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. The firm had revenue of $642.44 million for the quarter, compared to analyst estimates of $649.34 million. As a group, equities research analysts predict that Teladoc Health, Inc. will post -1.18 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Stifel Nicolaus decreased their target price on Teladoc Health from $16.00 to $9.00 and set a "hold" rating for the company in a research note on Thursday, August 1st. Barclays decreased their target price on Teladoc Health from $20.00 to $10.00 and set an "overweight" rating for the company in a research note on Thursday, August 1st. Jefferies Financial Group boosted their price objective on Teladoc Health from $8.00 to $10.00 and gave the company a "hold" rating in a research note on Tuesday, September 17th. Evercore ISI boosted their price objective on Teladoc Health from $8.00 to $9.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. Finally, Oppenheimer reduced their price objective on Teladoc Health from $21.00 to $17.00 and set an "outperform" rating for the company in a research note on Thursday, August 1st. Fourteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $11.81.

Insider Buying and Selling

In related news, CEO Laizer Kornwasser sold 10,879 shares of the company's stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $88,555.06. Following the transaction, the chief executive officer now owns 99,929 shares of the company's stock, valued at $813,422.06. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the business's stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the sale, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Laizer Kornwasser sold 10,879 shares of the business's stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $88,555.06. Following the sale, the chief executive officer now owns 99,929 shares in the company, valued at approximately $813,422.06. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 57,377 shares of company stock valued at $438,054 over the last quarter. Company insiders own 0.95% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.